Literature DB >> 44874

Arginine-induced hypophosphatemia and hyperkaliemia in man.

F Massara, S Martelli, E Ghigo, F Camanni, G M Molinatti.   

Abstract

The effects of a 0.5 g/kg body weight arginine infusion on plasma inorganic phosphates and potassium were examined in nineteen normal subjects. Plasma phosphorus displayed a highly significant (p less than 0.001) fall with a maximum depression below baseline of 1.11 +/- 0.15 mg/100 ml or 33 +/- 3% (mean +/- SEM); there was a significant correlation (p less than 0.01) between this fall and the insulin peaks induced by arginine. Plasma potassium levels displayed a distinct and significant increase in eleven of the twelve subjects studied; the maximum increase above baseline was 1.02 +/- 0.14 mEq/1 or 27 +/- 4.5% (p less than 0.001). No change occurred in blood pH values determined in four subjects. In six normal subjects, the test was repeated with the addition of somatostatin (250 micrograms bolus, followed by 500 micrograms/hr), which abolished the insulin and growth hormone response to arginine. It also abolished the fall in plasma phosphorus but appeared (if anything) to augment the increase in potassium. These findings show that arginine is responsible for a fall in plasma phosphorus related to the insulin response, and for an increase in plasma potassium of clinical significance, the mechanism(s) of which, however, are still obscure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 44874

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  4 in total

1.  Rise in urea concentration after arginine hydrochloride infusion.

Authors:  A Pedrotti; O Grigoras; J P Guignard
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

2.  A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids.

Authors:  S Charles; T Tamagawa; J C Henquin
Journal:  Biochem J       Date:  1982-11-15       Impact factor: 3.857

Review 3.  Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Authors:  Edgar J Rolleman; Marleen Melis; Roelf Valkema; Otto C Boerman; Eric P Krenning; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-14       Impact factor: 9.236

4.  Tissue-specific regulation of potassium homeostasis by high doses of cationic amino acids.

Authors:  Asunción Cremades; Jesús Del Rio-Garcia; Ana Lambertos; Carlos López-Garcia; Rafael Peñafiel
Journal:  Springerplus       Date:  2016-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.